The American Journal of Medicine
Volume 103, Issue 6 , Pages 462-467, December 1997

Upper Gastrointestinal Adverse Events and Cyclical Etidronate☆

  • Tjeerd van Staa MD

      Affiliations

    • Procter & Gamble Pharmaceuticals, Lovett House, Lovett Road, Staines, United Kingdom
    • ,
  • Lucien Abenhaim MD

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill University Montreal, Canada
    • Center for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Canada
    • Corresponding Author InformationL Abenhaim, MD, Center for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis-Jewish General Hospital, 3755, chemin de la Co̊te-Ste-Catherine, Montreal, Canada H3T 1E2.
    • ,
  • Cyrus Cooper MD

      Affiliations

    • Medical Research Council Environmental Epidemiology Unit, Southampton University Hospital, Southampton, United Kingdom

Received 14 January 1997; accepted 21 May 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by Procter & Gamble Pharmaceuticals.

PII: S0002-9343(97)00242-8

The American Journal of Medicine
Volume 103, Issue 6 , Pages 462-467, December 1997

Article Tools

* Image Usage & Resolution